HOME Top Market Reports NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019

NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019

By: marketsandmarkets.com
Publishing Date: June 2014
Report Code: MD 2549

 

Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The global newborn screening market was valued at an estimated $438.9 million in 2013 and is expected to grow at a CAGR of 11.0% in the next five years. This high growth is mainly attributed to the benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases, and conferences and symposiums related to the usage of new technologies. Furthermore, various awareness programs and conferences are being organized across the globe, which is likely to drive the market growth. However, factors such as lack of trained professional infrastructure and socio-economic barriers are expected to hinder the market growth.

North America dominates the newborn screening market. Asia is poised to grow at the highest CAGR during the forecast period owing to support provided by foreign countries for enhancing screening services. Apart from this, factors such as increased government support and investment by major players in the region are expected to provide required impetus for the growth of this market.

The prominent players in the newborn screening market are AB SCIEX (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.), PerkinElmer Inc. (U.S.), Trivitron Healthcare (India), and Waters Corporation (U.S.).

Scope of the Report

This research report covers the global newborn screening market by type, technology, products, and geography.

By Test Type

  • Dry Blood Spot Test
  • Hearing Screen Test
  • Critical Congenital Heart Disease (CCHD) Test

By Technology

  • Tandem Mass Spectrometry
  • Electrophoresis
  • Enzymes and Immunoassays
  • DNA-based Assays
  • Hearing Screen Technology
  • Pulse Oximetry Technology

By Product

  • Instruments
    • Newborn Disorder Screening Instruments
    • Hearing Screening Instruments
      • Hearing Screening Devices
      • Hearing Screening Accessories
    • Pulse Oximetry Instruments
  • Reagents and Assay Kits

By Geography

  • North America
  • South America
  • Europe
  • Asia
  • Rest of the World

Table of Contents 
 
1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
          1.1.1 Key Insights From the Report
    1.2 Scope of the Report
          1.2.1 Markets Covered
          1.2.2 Limitations of the Study
    1.3 Stakeholders
    1.4 Research Methodology
          1.4.1 Market Size Estimation
          1.4.2 Market Crackdown & Data Triangulation
          1.4.3 Market Share Estimation
          1.4.4 Key Data From Primary Sources
          1.4.5 Key Data From Secondary Sources
          1.4.6 Assumptions

2 Executive Summary (Page No. - 32)

3 Premium Insights (Page No. - 36)
    3.1 Technology Trends
    3.2 Winning Imperative
          3.2.1 Investments in R&D Activities for Product Innovation
    3.3 Porter’s Five forces Analysis
          3.3.1 Threat of New Entrants
          3.3.2 Bargaining Power of Suppliers
          3.3.3 Bargaining Power of Buyers
          3.3.4 Rivalry Amongst Existing Players
          3.3.5 Threat of Subsitutes
    3.4 Regulatory Environment
    3.5 Reimbursement Scenario
    3.6 Technology Life Cycle
    3.7 Strategic Benchmarking

4 Market Overview (Page No. - 47)
    4.1 Introduction
          4.1.1 Common Indications In Newborn Screening
                  4.1.1.1 Phenylketonuria (PKU)
                  4.1.1.2 Congenital Hypothyroidism (CH)
                  4.1.1.3 Galactosemia
                  4.1.1.4 Biotinidase Deficiency
                  4.1.1.5 Congenital Adrenal Hyperplasia (CAH)
                  4.1.1.6 Cystic Fibrosis (CF)
                  4.1.1.7 Sickle Cell Disease
                  4.1.1.8 Maple Syrup Urine Disease
                  4.1.1.9 Tryosinemia
                  4.1.1.10 Medium-Chain Acyl-Coa Dehydrogenase (MCAD) Deficiency
                  4.1.1.11 Congenital Toxoplasmosis
                  4.1.1.12 Newborn Hearing Loss
                  4.1.1.13 Critical Congenital Heart Diseases
          4.1.2 Newborn Screening Confirmatory Test
    4.2 Market Segmentation
    4.3 Market Dynamics
          4.3.1 Drivers
                  4.3.1.1 Benefits Related to Newborn Screening to Propel the Growth of the Market
                  4.3.1.2 Legislations and Mandates Demand the Implementation of Newborn Testing Programs
                  4.3.1.3 Government Support, An Impetus for the Newborn Screening Market
                  4.3.1.4 Rising Awareness to Trigger the Growth of the Market
                  4.3.1.5 Technological Innovations to Propel the Growth of the Market
                  4.3.1.6 Expanding Panel of Newborn Diseases to Bolster the Growth of the Market
                  4.3.1.7 Rising Incidences of Critical Congenital Heart Defects (CCHD) to Propel the CCHD Screening Market
          4.3.2 Restraints
                  4.3.2.1 Lack of Professional Infrastructure May Hinder the Growth of the Market
                  4.3.2.2 Socio-Economic Barriers Are Likely to Restrain the Growth of the Market
          4.3.3 Opportunities
                  4.3.3.1 Asian Region Presents Significant Growth Opportunities
                  4.3.3.2 Screening of Genetic Disorders
                  4.3.3.3 Next-Generation Sequencing(Ngs), An Upcoming Technology in the Newborn Screening Market
                  4.3.3.4 Digital Microfluidics, A New Opportunity Area for the Newborn Screening Market
          4.3.4 Challenges
                  4.3.4.1 High Cost of Automation
                  4.3.4.2 Survival of Small Players and New Entrants
                  4.3.4.3 Lack of Uniformity of Newborn Testing Policies and Procedures Across the Globe
    4.4 Market Share Analysis
          4.4.1 Global Newborn Screening Dried Blood Spot Test Market
                  4.4.1.1 North America: Newborn Screening Dried Blood Spot Test Market
                  4.4.1.2 Europe: Newborn Testing Dried Blood Spot Test Market
                  4.4.1.3 Asia: Newborn Screening Dried Blood Spot Test Market
                  4.4.1.4 ROW: Newborn Testiing Dried Blood Spot Test Market
          4.4.2 Newborn Screening Market for Critical Congenital Heart Diseases
          4.4.3 Newborn Hearing Screening Market

5 Newborn Screening Market, By Test Type (Page No. - 78)
    5.1 Introduction
    5.2 Dry Blood Spot Test
    5.3 Hearing Screen Test
    5.4 Critical Congenital Heart Diseases (CCHD) Test

6 Newborn Screening Market, By Technology (Page No. - 89)
    6.1 Introduction
    6.2 Tandem Mass Spectrometry (TMS)
    6.3 Electrophoresis
    6.4 Immunoassays and Enzymatic Assays
    6.5 Dna-Based Assays
    6.6 Hearing Screen Technology
    6.7 Pulse Oximetry Screening Technology

7 Newborn Screening Market, By Product Type (Page No. - 105)
    7.1 Introduction
    7.2 Instruments
          7.2.1 Introduction
          7.2.2 Newborn Disorder Screening Instruments
          7.2.3 Newborn Hearing Screening Instruments
                  7.2.3.1 Hearing Screening Devices
                  7.2.3.2 Hearing Screening Accessories
          7.2.4 Pulse Oximeters
    7.3 Reagents and Assay Kits

8 Newborn Screening Market, By Geography (Page No. - 123)
    8.1 Introduction
    8.2 North America
          8.2.1 Need for Reducing Healthcare Costs, A Major Driver for the U.S. Newborn Screening Market
          8.2.2 Government Support, An Impetus for the Market
          8.2.3 Newborn Screening Program in Canada
          8.2.4 Newborn Hearing Screening Program in Canada
          8.2.5 Issues Over Privacy Rights of Families May Hinder the Growth of the Canadian Market
          8.2.6 Symposiums and Meetings to Trigger the Growth of the Newborn Screening Market
    8.3 South America
          8.3.1 Growth in the South American Market to Be Hinged At Brazil
          8.3.2 Research Studies to Enhance the Newborn Testing Program
          8.3.3 Lack of Trained Professionals to Hinder the Growth of the Newborn Hearing Screening Market
    8.4 Europe
          8.4.1 European Union Initiatives to Propel the Growth of the Market
          8.4.2 Newborn Testing Program in Various European Countries
          8.4.3 Conferences to Raise Awareness Regarding CCHD Screening
          8.4.4 Newborn Hearing Screening Program in Europe
          8.4.5 Government initiatives to Bolster the Growth of the European Market
          8.4.6 Launch of New & Advanced Products to Propel the Growth of the European Market
          8.4.7 Conferences to Boost the Growth of the Newborn Screening Market
    8.5 Asia
          8.5.1 Government Initiatives to Drive the Growth of the Asian Market
                  8.5.1.1 Japanese Government Initiatives
                  8.5.1.2 Indian Government Initiatives
                  8.5.1.3 Philippines Government Initiatives
          8.5.2 Collaboration Amongst Leading Players and Government to Boost the Chinese Market
    8.6 ROW
          8.6.1 Newborn Screening Program in Australia and New Zealand
          8.6.2 Newborn Testing Program in South Africa
          8.6.3 African & Middle Eastern Countries Taking Initiatives to Launch and Improve their Newborn Screening Programs
          8.6.4 Support By foreign Countries to Boost the ROW Market

9 Competitive Landscape (Page No. - 179)
    9.1 Introduction
    9.2 Partnerships, Agreements, Collaborations, and Contracts
    9.3 New Product Launches
    9.4 Expansions
    9.5 Acquisitions
    9.6 Approvals

10 Company Profiles (Page No. - 194)
     (Overview, Financials, Products & Services, Strategy, & Developments)* 
     10.1 AB Sciex LLC (A Subsidiary of Danaher Corporation)
     10.2 Perkinelmer, Inc.
     10.3 Waters Corporation
     10.4 Natus Medical Incorporated
     10.5 Masimo Corporation
     10.6 Agilent Technologies Inc.
     10.7 Bio-Rad Laboratories, Inc.
     10.8 Covidien PLC
     10.9 GE Healthcare (A Subsidiary of General Electric Company)
     10.10 Trivitron Healthcare
 
*Details on Products & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies. 


List of Tables (70 Tables)

Table 1 Scope: Global Newborn Screening Market
Table 2 Global Newborn Screening Market Size, By Test Type, 2012–2019 ($Million) 
Table 3 Global Market Size, By Geography, 2012–2019 ($Million) 
Table 4 Newborn Screening Confirmatory Tests and Technologies
Table 5 North America: Market Share Analysis, By Key Players, 2013
Table 6 Europe: Market Share Analysis, By Key Players, 2013
Table 7 Asia: Market Share Analysis, By Key Players, 2013
Table 8 ROW: Market Share Analysis, By Key Players, 2013
Table 9 Global Newborn Critical Congenital Heart Disease Screening Market, By Ranking
Table 10 Global Newborn Hearing Screening Market, By Key Player, 2013
Table 11 Global Market Size, By Test Type, 2012–2019 ($Million) 
Table 12 Newborn Screening Test Type Market Size, By Geography, 2012–2019 ($Million)
Table 13 Dry Blood Spot Test Market Size, By Geography, 2012–2019 ($Million) 
Table 14 Hearing Screen Test Market Size, By Geography, 2012–2019 ($Million) 
Table 15 Critical Congenital Heart Diseases (CCHD) Test Market Size, By Geography, 2012–2019 ($Million)
Table 16 Global Market Size, By Technology, 2012–2019 ($Million) 
Table 17 Newborn Screening Technology Market Size, By Geography, 2012–2019 ($Million)
Table 18 Tandem Mass Spectrometry Market Size, By Geography, 2012–2019 ($Million) 
Table 19 Electrophoresis Market Size, By Geography, 2012–2019 ($Million) 
Table 20 Immunoassay and Enzymatic Assays Market Size, By Geography, 2012–2019 ($Million) 
Table 21 Dna-Based Assay Market Size, By Geography, 2012–2019 ($Million) 
Table 22 Hearing Screen Technology Market Size, By Geography, 2012–2019 ($Million) 
Table 23 Pulse Oximetry Screening Technology Market Size, By Geography, 2012–2019 ($Million) 
Table 24 Global Newborn Screening Market Size, By Product Type, 2012–2019 ($Million)
Table 25 Newborn Testing Products Market Size, By Geography, 2012–2019 ($Million)
Table 26 Newborn Screening Instruments Market Size, By Type, 2012–2019 ($Million) 
Table 27 Newborn Testing Instruments Market Size, By Geography, 2012–2019 ($Million)
Table 28 Newborn Disorder Screening Instruments Market Size, By Geography, 2012–2019 ($Million) 
Table 29 Newborn Hearing Screening Instruments Market Size, By Product Type, 2012–2019 ($Million) 
Table 30 Newborn Hearing Screening Instruments Market Size, By Geography, 2012–2019 ($Million) 
Table 31 Hearing Screening Devices Market Size, By Geography, 2012–2019 ($Million) 
Table 32 Hearing Screening Accessories Market Size, By Geography, 2012–2019 ($Million)
Table 33 Newborn Pulse Oximeters Market Size, By Geography, 2012–2019 ($Million) 
Table 34 Reagents and Assay Kits Market Size, By Geography, 2012–2019 ($Million) 
Table 35 Global Market Size, By Geography, 2012–2019 ($Million) 
Table 36 U.S.: Newborn Disorder Screening Status
Table 37 U.S.: Critical Congenital Heart Diseases (CCHD) Screening Implementation
Table 38 Canada: Newborn Disorder Screening Status
Table 39 North America: Newborn Screening Market Size, By Technology, 2012–2019 ($Million) 
Table 40 North America: Market Size, By Test Type, 2012–2019 ($Million)
Table 41 North America: Market Size, By Product Type, 2012–2019 ($Million)
Table 42 North America: Newborn Testing Instruments Market Size, By Type, 2012–2019 ($Million)
Table 43 North America: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012–2019 ($Million)
Table 44 South America: Market Size, By Technology, 2012–2019 ($Million) 
Table 45 South America: Market Size, By Test Type, 2012–2019 ($Million)
Table 46 South America: Newborn Screening Market Size, By Product Type, 2012–2019 ($Million)
Table 47 South America: Newborn Testing Instruments Market Size, By Type, 2012–2019 ($Million)
Table 48 South America: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012–2019 ($Million)
Table 49 Europe: Newborn Screening Market Size, By Technology, 2012–2019 ($Million)
Table 50 Europe: Market Size, By Test Type, 2012–2019 ($Million) 
Table 51 Europe: Market Size, By Product Type, 2012–2019 ($Million)
Table 52 Europe: Newborn Screening Instruments Market Size, By Type, 2012–2019 ($Million) 
Table 53 Europe: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012–2019 ($Million)
Table 55 Asia: Market Size, By Technology, 2012–2019 ($Million) 
Table 56 Asia: Market Size, By Test Type, 2012–2019 ($Million) 
Table 57 Asia: Market Size, By Product Type, 2012–2019 ($Million) 
Table 58 Asia: Newborn Screening Instruments Market Size, By Type, 2012–2019 ($Million) 
Table 59 Asia: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012–2019 ($Million)
Table 60 Newborn Hearing Screening Program
Table 61 ROW: Newborn Screening Market Size, By Technolgy, 2012–2019 ($Million) 
Table 62 ROW: Market Size, By Test Type, 2012–2019 ($Million) 
Table 63 ROW: Market Size, By Product Type, 2012–2019 ($Million) 
Table 64 ROW: Newborn Testing Instruments Market Size, By Type, 2012–2019 ($Million)
Table 65 ROW: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012–2019 ($Million)
Table 66 Partnerships, Agreements, Collaborations, and Contracts, 2011–2014
Table 67 New Product Launches, 2011–2014
Table 68 Expansions, 2011–2014
Table 69 Acquisitions, 2011–2014
Table 70 Approvals,2011–2014


List of Figures (16 Figures)

Figure 1 forecast Model
Figure 2 Market Size Estimation Methodology
Figure 3 Data Triangulation
Figure 4 Porter’s Five forces Analysis
Figure 5 Technology Life Cycle
Figure 6 Dried Blood Spot Test Instrument Manufacturers: Strategy
Figure 7 Market Segmentation: Newborn Screening Market
Figure 8 Market Dynamics
Figure 9 Market Share Analysis, By Key Players, 2013
Figure 10 New Born Screening By Test Type
Figure 11 Global Market Size, By Test Type, 2012–2019 ($Million) 
Figure 12 Market By Technology
Figure 13 Global Market, By Product Type, 2013
Figure 14 Newborn Screening: Tapped & Untapped Markets
Figure 15 High Growth Potential Market
Figure 16 Key Growth Strategies, 2011–2014

This report studies the newborn screening market by test type, technology, product, and geography.

Newborn screening is a test in which the newborns are screened for a panel of inborn diseases that can lead to disabilities or even death. The newborn testing allows early detection and management of congenital disorders, thereby providing a better life to the affected infant. This market is driven by several factors which include benefits offered by newborn testing programs, legislations and mandates, technological advancements, government support, and the expanding panel of newborn diseases. Government initiatives in the forms of grants and funds have provided an impetus to the market. Technological advancements, which help in introduction of new and innovative devices in the market, are another major factor driving the growth of the market. The relatively untapped Asian market and advent of next-generation sequencing and digital microfluidics technology have opened an array of opportunities for market to grow. However, factors such as lack of trained professional infrastructure and socio-economical barriers may restrain the growth of this market.

The global newborn screening market, estimated at $438.9 million in 2013, is expected to reach $819.6 million by 2019, growing at a CAGR of 11.0% from 2013 to 2019. The market is segmented on the basis of types, technologies, products, and geography.

Based on types, the newborn screening market is segmented into dry blood spot test, hearing screen test, and pulse oximetry test. The dry blood spot test market is slated to grow at the highest CAGR owing to the technological advancements due to which new and advanced products are being launched in the market.

Based on technologies, the market is subdivided into tandem mass spectroscopy, electrophoresis, enzyme and immunoassays, DNA-based assays, hearing screen technology, and pulse oximetry. The tandem mass spectroscopy market is expected to witness the highest growth. This high growth can be attributed to time-effectiveness and cost effectiveness provided by mass spectrometry as compared to the enzyme assays and immunoassays technology. These advantages are the major reasons for the growth of this market.

The newborn screening products market includes instruments, reagents, and assay kits. The instruments market accounts for the largest share of the global products market, followed by reagents and assay kits. The high share of the instruments market can be attributed to the wide usage of newborn screening devices across the globe.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports